Whit Mayo
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
190
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RF Regions Financial | Maintains: Equal-Weight | $22 → $24 | $23.56 | +1.87% | 4 | Oct 21, 2024 | |
| MS Morgan Stanley | Maintains: Underweight | $95 → $107 | $116.85 | -8.43% | 4 | Oct 17, 2024 | |
| PNC PNC Financial | Maintains: Overweight | $204 → $215 | $187.15 | +14.88% | 4 | Oct 16, 2024 | |
| BK BNY Mellon | Maintains: Equal-Weight | $69 → $79 | $75.31 | +4.90% | 3 | Oct 14, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $260.71 | -4.11% | 12 | Oct 2, 2024 | |
| ARDT Ardent Health Partners | Initiates: Outperform | $23 | $17.70 | +29.94% | 1 | Aug 12, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $98.91 | +1.10% | 1 | Jul 10, 2024 | |
| AIRS AirSculpt Technologies | Downgrades: Market Perform | $5 | $5.86 | -14.68% | 4 | May 14, 2024 | |
| EHAB Enhabit | Upgrades: Market Perform | $8.5 | $7.25 | +17.24% | 1 | May 14, 2024 | |
| FITB Fifth Third Bancorp | Maintains: Overweight | $40 → $44 | $43.14 | +1.99% | 3 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $44 | $41.76 | +5.36% | 3 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $13 | $10.50 | +23.81% | 9 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $17.25 | -13.04% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $45 → $52 | $62.89 | -17.32% | 2 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $55 | $63.71 | -13.67% | 3 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $567.56 | -1.33% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $205.26 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $50 → $38 | $51.44 | -26.13% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $390 | $519.35 | -24.91% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $92.80 | +4.53% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $155 | $192.25 | -19.38% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $20 | $17.19 | +16.35% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $316.49 | +5.85% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $580 | $414.01 | +40.09% | 3 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $96 → $85 | $95.49 | -10.99% | 16 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $357.19 | -19.93% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $28.75 | +39.13% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $18.99 | +105.37% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $4.20 | -64.29% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $2.70 | +1,011.11% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $15.21 | +5.19% | 10 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $156.13 | -64.77% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $42.02 | +145.12% | 10 | Aug 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $73.23 | +138.97% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $12.95 | +46.72% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $4.20 | -4.76% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $227.10 | -10.61% | 2 | May 1, 2018 |
Regions Financial
Oct 21, 2024
Maintains: Equal-Weight
Price Target: $22 → $24
Current: $23.56
Upside: +1.87%
Morgan Stanley
Oct 17, 2024
Maintains: Underweight
Price Target: $95 → $107
Current: $116.85
Upside: -8.43%
PNC Financial
Oct 16, 2024
Maintains: Overweight
Price Target: $204 → $215
Current: $187.15
Upside: +14.88%
BNY Mellon
Oct 14, 2024
Maintains: Equal-Weight
Price Target: $69 → $79
Current: $75.31
Upside: +4.90%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $260.71
Upside: -4.11%
Ardent Health Partners
Aug 12, 2024
Initiates: Outperform
Price Target: $23
Current: $17.70
Upside: +29.94%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $98.91
Upside: +1.10%
AirSculpt Technologies
May 14, 2024
Downgrades: Market Perform
Price Target: $5
Current: $5.86
Upside: -14.68%
Enhabit
May 14, 2024
Upgrades: Market Perform
Price Target: $8.5
Current: $7.25
Upside: +17.24%
Fifth Third Bancorp
Mar 28, 2024
Maintains: Overweight
Price Target: $40 → $44
Current: $43.14
Upside: +1.99%
Mar 28, 2024
Maintains: Overweight
Price Target: $40 → $44
Current: $41.76
Upside: +5.36%
Feb 28, 2024
Maintains: Buy
Price Target: $9 → $13
Current: $10.50
Upside: +23.81%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $17.25
Upside: -13.04%
Dec 14, 2023
Maintains: Underweight
Price Target: $45 → $52
Current: $62.89
Upside: -17.32%
Aug 23, 2023
Maintains: Overweight
Price Target: $60 → $55
Current: $63.71
Upside: -13.67%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $567.56
Upside: -1.33%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $205.26
Upside: -
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $50 → $38
Current: $51.44
Upside: -26.13%
Apr 3, 2023
Maintains: Overweight
Price Target: $420 → $390
Current: $519.35
Upside: -24.91%
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $92.80
Upside: +4.53%
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $192.25
Upside: -19.38%
Apr 3, 2023
Maintains: Overweight
Price Target: $21 → $20
Current: $17.19
Upside: +16.35%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $316.49
Upside: +5.85%
Jan 26, 2023
Reiterates: Outperform
Price Target: $580
Current: $414.01
Upside: +40.09%
Jan 5, 2023
Maintains: Market Perform
Price Target: $96 → $85
Current: $95.49
Upside: -10.99%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $357.19
Upside: -19.93%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $28.75
Upside: +39.13%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $18.99
Upside: +105.37%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $4.20
Upside: -64.29%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $2.70
Upside: +1,011.11%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $15.21
Upside: +5.19%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $156.13
Upside: -64.77%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $42.02
Upside: +145.12%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $73.23
Upside: +138.97%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $12.95
Upside: +46.72%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $4.20
Upside: -4.76%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $227.10
Upside: -10.61%